Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

EDIT

Editas Medicine (EDIT)

Editas Medicine Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:EDIT
일자시간출처헤드라인심볼기업
2024/06/1419:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EDITEditas Medicine Inc
2024/06/1416:01GlobeNewswire Inc.Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association (EHA) Annual CongressNASDAQ:EDITEditas Medicine Inc
2024/06/1416:00GlobeNewswire Inc.Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patients with Transfusion-dependent Beta Thalassemia, Presented at the European Hematology Association (EHA) Annual CongressNASDAQ:EDITEditas Medicine Inc
2024/06/0705:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
2024/06/0705:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
2024/06/0406:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
2024/06/0406:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
2024/06/0405:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
2024/06/0405:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
2024/06/0405:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
2024/06/0105:21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EDITEditas Medicine Inc
2024/06/0105:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EDITEditas Medicine Inc
2024/06/0105:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EDITEditas Medicine Inc
2024/05/2305:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
2024/05/1019:00GlobeNewswire Inc.Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual MeetingNASDAQ:EDITEditas Medicine Inc
2024/05/0905:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EDITEditas Medicine Inc
2024/05/0821:29IH Market NewsU.S. Futures Slightly Dip Amid Corporate Earnings and Quiet Economic Calendar, Oil Prices FallNASDAQ:EDITEditas Medicine Inc
2024/05/0820:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EDITEditas Medicine Inc
2024/05/0820:00GlobeNewswire Inc.Editas Medicine Announces First Quarter 2024 Results and Business UpdatesNASDAQ:EDITEditas Medicine Inc
2024/05/0220:00GlobeNewswire Inc.Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor EventsNASDAQ:EDITEditas Medicine Inc
2024/05/0121:00GlobeNewswire Inc.Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell CollaborationNASDAQ:EDITEditas Medicine Inc
2024/04/2305:31GlobeNewswire Inc.Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual MeetingNASDAQ:EDITEditas Medicine Inc
2024/03/0610:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
2024/03/0610:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
2024/03/0610:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
2024/03/0609:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EDITEditas Medicine Inc
2024/03/0507:58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EDITEditas Medicine Inc
2024/02/2907:13Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:EDITEditas Medicine Inc
2024/02/2906:39Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:EDITEditas Medicine Inc
2024/02/2821:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EDITEditas Medicine Inc
 검색 관련기사 보기:NASDAQ:EDIT